Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294267 · ClinicalTrials.gov registry record · NA
Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation
A NA study, sponsored by Vivek Reddy.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01294267 is a NA study that has completed, run by Vivek Reddy. The registered enrollment target is 20 participants.
The verdict
NCT01294267, a NA study, has completed, sponsored by Vivek Reddy.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the safety and feasibility of the Impella 2.5 Circulatory Support System for use during mapping and ablation of ventricular tachycardia in the setting of Ventricular dysfunction.
Interventions
- DEVICE Circulatory Support System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01294267
The ClinicalTrials.gov registry entry for NCT01294267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Circulatory Support System is the first listed.
NCT01294267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01294267 about?
NCT01294267 is a clinical study titled "Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation". The purpose of this research study is to evaluate the safety and feasibility of the Impella 2.5 Circulatory Support System for use during mapping and ablation of ventricular tachycardia in the setting of Ventricular dysfunction.
What is the current status of trial NCT01294267?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01294267?
The interventions under investigation include: Circulatory Support System (DEVICE).
Who is sponsoring clinical trial NCT01294267?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.